![Kohichiro Yoshino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kohichiro Yoshino
President at
CARNA BIOSCIENCES, INC.
Net worth: 917 968 $ as of 30/09/2026
Profile
Kohichiro Yoshino is President & Representative Director at Carna Biosciences, Inc. since 2017.
Holds the position of Independent Outside Director at MEDINET Co., Ltd. and Kringle Pharma, Inc. since 2018.
Serves as Director at CarnaBio USA, Inc. since 2011.
Formerly President & Representative Director at ProbeX, Inc. Completed a doctorate at Kyoto University and graduate studies at the Institute of Science Tokyo.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 31/12/2025 | 333,900 ( 1.58% ) | 917 968 $ | 30/09/2026 |
Kohichiro Yoshino active positions
| Companies | Position | Start |
|---|---|---|
| CARNA BIOSCIENCES, INC. | President | 10/04/2003 |
| MEDINET CO., LTD. | Director/Board Member | 01/12/2018 |
| KRINGLE PHARMA, INC. | Director/Board Member | 01/12/2018 |
CarnaBio USA, Inc.
 CarnaBio USA, Inc. Medical DistributorsDistribution Services Wholesales kinases protein, substrates and biotinylates kinases products | Director/Board Member | 01/03/2011 |
Former positions of Kohichiro Yoshino
| Companies | Position | End |
|---|---|---|
ProbeX, Inc.
 ProbeX, Inc. Medical/Nursing ServicesHealth Services Develops, manufactures, and distributes molecular imaging probe reagents | President | - |
Education of Kohichiro Yoshino
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
31
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Carna Biosciences, Inc.
 Carna Biosciences, Inc. BiotechnologyHealth Technology Engages in the drug discovery business | Health Technology |
MEDINET Co., Ltd.
 MEDINET Co., Ltd. BiotechnologyHealth Technology Engages in the contract development and manufacturing organization which provides regenerative medicine & cell therapy services | Health Technology |
Kyoto University
 Kyoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tokyo Institute of Technology
 Tokyo Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CarnaBio USA, Inc.
CarnaBio USA, Inc. Medical DistributorsDistribution Services Wholesales kinases protein, substrates and biotinylates kinases products | Distribution Services |
ProbeX, Inc.
ProbeX, Inc. Medical/Nursing ServicesHealth Services Develops, manufactures, and distributes molecular imaging probe reagents | Health Services |
Kringle Pharma, Inc.
 Kringle Pharma, Inc. BiotechnologyHealth Technology Researches and develops treatments for regenerative medicine and cancer therapy | Health Technology |
- Stock Market
- Insiders
- Kohichiro Yoshino
